- Research
- Open access
- Published:
Clinical value of grayscale ultrasound combined with real-time shear wave elastography nomogram in risk prediction of thyroid cancer
BMC Medical Imaging volume 23, Article number: 123 (2023)
Abstract
Objectives
This study constructed a nomogram based on grayscale ultrasound features and real-time shear wave elastography (SWE) parameters to predict thyroid cancer.
Methods
Clinical data of 217 thyroid nodules of 201 patients who underwent grayscale ultrasound, real-time SWE, and thyroid function laboratory examination in Ma’anshan People’s Hospital from January 2019 to December 2020 were retrospectively analyzed. The subjects were divided into a benign nodule group (106 nodules) and a malignant nodule group (111 nodules). The differences in grayscale ultrasound features, quantitative parameters of real-time SWE, and laboratory results of thyroid function between benign and malignant thyroid nodules were analyzed. We used a chi-square test for categorical variables and a t-test for continuous variables. Then, the independent risk factors for thyroid cancer were analyzed using multivariate logistic regression. Based on the independent risk factors, a nomogram for predicting thyroid cancer risk was constructed using the RMS package of the R software.
Results
Multivariate logistic regression showed that the grayscale ultrasound features of thyroid nodules were the shape, margin, echogenicity, and echogenic foci of the nodules,the maximum Young’s modulus (SWE-max) of thyroid nodules, and the ratio of thyroid nodule and peripheral gland (SWE-ratio) measured by real-time SWE were independent risk factors for thyroid cancer (all p < 0.05), and the other variables had no statistical difference (p > 0.05). Based on the shape (OR = 5.160, 95% CI: 2.252–11.825), the margin (OR = 9.647, 95% CI: 2.048–45.443), the echogenicity (OR = 6.512, 95% CI: 1.729–24.524), the echogenic foci (OR = 2.049, 95% CI: 1.118–3.756), and the maximum Young’s modulus (SWE-max) (OR = 1.296, 95% CI: 1.140–1.473), the SWE-ratio (OR = 2.001, 95% CI: 1.403–2.854) of the thyroid nodule to peripheral gland was used to establish the related nomogram prediction model. The bootstrap self-sampling method was used to verify the model. The consistency index (C-index) was 0.979, ROC curve was used to analyze the nomogram scores of all patients, and the AUC of nomogram prediction of thyroid cancer was 0.976, indicating that the nomogram model had high accuracy in the risk prediction of thyroid cancer.
Conclusions
The nomogram model of grayscale ultrasound features combined with SWE parameters can accurately predict thyroid cancer.
Introduction
Thyroid nodules are a common disease of the endocrine system [1]. Thyroid cancer accounts for only 5-15% of thyroid nodules, but the incidence rate is increasing by 4-6.2% every year [2, 3]. Ultrasound (US) is the preferred imaging method for the diagnosis of thyroid nodules. The grayscale acoustic characteristics of thyroid nodules could be used to characterize thyroid nodules. Scholars from different countries have established their own hierarchical risk assessment system (Thyroid Imaging Reporting and Data System, TI-RADS) according to the grayscale US characteristics of thyroid nodules [4,5,6,7,8,9,10]. Despite the widespread use of TI-RADS, the interpretation of thyroid images remains inconsistent, as over 10 different TI-RADS systems are currently used across Chinese hospitals [11]. Additionally, the sensitivity and specificity of these systems in detecting thyroid cancer vary widely, making it challenging to compare data between hospitals.
Shear wave elastography (SWE) is a non-invasive medical imaging technique used to evaluate tissue elasticity by measuring the propagation speed of high-frequency ultrasound waves within tissues. This new imaging technology has improved the detection of various cancer, particularly thyroid cancer [12,13,14,15]. In addition, some studies have found a correlation between the extent of the disease on SWE and the serum thyroid-stimulating hormone (TSH) concentrations. However, these studies had conflicting results, and it remains unclear whether TSH promotes or protects against thyroid cancer [16, 17].
In order to address these challenges, we developed a novel machine-learning algorithm to identify the most relevant risk factors for thyroid cancer based on US grayscale characteristics of the nodules, two-dimensional real-time SWE measurements, and patient serum indices. In addition, we also created a nomogram to facilitate the implementation of the machine learning model clinically. Nomograms are statistical models based on logistic regression or Cox regression that can quantitatively and graphically represent prediction indicators and provide a more intuitive evaluation of clinical events [18,19,20,21]. This innovative approach could potentially provide a more accurate individualized risk assessment for thyroid nodules than the traditional TI-RADS system.
Materials and methods
Study population
We retrospectively analyzed the clinical data of 217 thyroid nodules in 201 patients who were subjected to grayscale US, SWE, and laboratory examination in Maanshan people’s Hospital from January 2019 to December 2020. The inclusion criterion was thyroid nodules confirmed by pathology during operation or cytological puncture. The exclusion criteria were nodules without surgery, poor or unsatisfactory cytological diagnosis of nodules, and atypical or unclear follicular lesions.
Grayscale US and SWE examinations
The grayscale US and SWE examinations were performed with the same sonography machine (Aixplorer; Supersonic Imagine, Paris, France) with a 5–14 MHz high-frequency linear transducer. The size of thyroid nodules was measured from longitudinal and transverse sections, and the shape of thyroid nodules was evaluated from transverse sections. The shape, margin, echogenicity, echogenic foci, and composition of thyroid nodules were observed and recorded. The shape was divided into wider than tall and taller than wide. The margin was divided into smooth, ill-defined, lobulated or irregular, and extrathyroidal extension. The echogenicity of the solid portion was classified as hyperechogenicity or isoechogenicity, hypoechogenicity, or very hypoechogenicity. The hyperechoic foci were divided into non-calcification or large comet-tail artifacts, macrocalcifications, peripheral (rim) calcifications, punctate echogenic foci, or mixed calcifications. The internal compositions were categorized as cystic or almost completely cystic, spongiform, mixed cystic and solid, and solid or almost completely solid.
SWE was used to examine the thyroid nodules. The maximum value (SWE-max), minimum value (SWE-min), mean value (SWE-mean), and the ratio of nodules to glands (SWE-ratio) were measured from longitudinal sections. During the measurements, the diameter of the Q-box was 2 mm, and the unit was kPa. The average of each value was calculated from measurements taken three times.
All images are collected and read by two radiologists with more than 10 years of experience.
Laboratory examination
The thyroid-related biochemical indexes were measured using a DPP-800 biochemical automatic analyzer (Roche, Germany). The free triiodothyronine (FT3), serum-free thyroxine (FT4), total triiodoethyl-3 (T3), total thyroxine-4 (T4), and TSH were also measured.
Statistical analysis
The R software (v3.6.1) was used for statistical analyses. Chi-square tests were used for categorical variables, and t-tests were used for numerical variables. Multivariate logistic regression was used to analyze the influencing factors in thyroid nodule malignant incidence. The independent risk factors were analyzed by R software’s RMS package, and the nomogram of thyroid cancer risk was constructed. The test level was 0.05, and p < 0.05 meant that the difference was statistically significant.
Diagnostic performance and validation of the nomogram
In the nomogram, a vertical line was made on the score axis at the top of the coordinate axis of the independent variable to obtain the corresponding score; the score of each independent variable was summed up to obtain the total score. The bootstrap self-sampling method was used to evaluate the results of the nomogram, and the consistency index (C-index) was obtained: C-index = 0.50–0.70 was low accuracy, 0.70–0.90 was moderate accuracy, and > 0.90 was high accuracy.
Results
Comparison of baseline data, US parameters, and laboratory tests for the prediction of thyroid malignancy
The results showed 28 males and 78 females with a mean age ± standard deviation (SD) of 51. 90 ± 10.13 years (range: 18–71 years) with benign nodules. There were 34 males and 77 females with a mean age ± SD of 44.28 ± 46 years (range: 21–65 years) with malignant nodules. The mean nodule size was 17.9 ± 1.16 mm (range: 3.8-69.9 mm).There were significant differences in the shape, margin, echogenicity of the solid portion, hyperechoic foci, internal composition of grayscale US nodule features, SWE-max, SWE-min, SWE-mean, and SWE-ratio between benign and malignant nodules (p < 0.05). There was no significant difference in other variables between the two groups (p > 0.05) (Table 1).
Analysis of influencing factors of thyroid cancer
The indexes with statistical significance in Table 1 were taken as independent variables and analyzed by multivariate logistic regression. The results showed that the shape, margin, echogenicity, echogenic foci, and elastic measurement values (SWE-max and SWE-ratio) were independent risk factors for thyroid cancer (Table 2).
Nomogram for predicting the risk of thyroid cancer
The nomogram was constructed with shape, margin, echogenicity, echogenic foci, and the elastic measurement values (SWE-max and SWE-ratio) as dependent variables. After bootstrap self-sampling, the C-index was 0.979, with high accuracy. In clinical application, the possible risk of thyroid cancer can be predicted using the nomogram. See Figs. 1 and 2.
An example of the proposed nomogram in use for the risk of thyroid malignancy
For example, patient one had a nodule with irregular margins, wider-than-tall, hypoechoic, and punctate echogenic foci (Fig. 3a). In addition, the SWE-Max value was 132.5 kPa, and the SWE-ratio was 5.0 (Fig. 3b). The proposed nomogram value was calculated at more than 99% (Fig. 3c). Pathology proves that it is a papillary thyroid carcinoma (Fig. 3d, h&e, ×40). Patient two had a nodule with ill-defined margins, wider-than-tall shape, hypoechoic, and punctate echogenic foci (Fig. 3e). In addition, the SWE-max value was 32.2 kPa, and the SWE-ratio was 1.9 (Fig. 3f). The proposed nomogram showed a risk of less than 12%. (Fig. 3g). Pathology confirmed it was a nodular goiter with fibrosis (Fig. 3h, h & e, ×40).
Discussion
Current assessment tools used to assess the risk of malignancy of thyroid nodules provide inconsistent results and are prone to observer variation. In addition, these tools are based solely on imaging or clinical features, thus further limiting their prediction accuracy. Therefore, this study aimed to develop a novel nomogram that integrates grayscale US characteristics, two-dimensional real-time shear wave elastography (SWE) measurements, and patient serum indices to characterize thyroid nodules.
This study used multiple logistic regression to analyze the current mainstream academic views. The results showed that the shape, margin, echogenicity, echogenic foci in grayscale US characteristics, and the values of SWE-Max and SWE-ratio were independent risk factors for thyroid cancer. Among them, the composition in grayscale US features was not an independent risk factor, which may be related to the included cases; there were no cystic or almost completely cystic cases. At present, simple cystic nodules are considered benign and do not need treatment [22]. Only three cases of cavernous nodules had pathological results. The other four grayscale US features are consistent in differentiating thyroid nodules. According to previous relevant studies, the elevated blood TSH level in patients with thyroid nodules is associated with an increased risk of thyroid cancer [23, 24]. TSH has no significance in the diagnosis of benign and malignant thyroid nodules in this study, which may be related to the number of samples in this study. SWE imaging is a new imaging technology developed in recent years. The American Thyroid Association (ATA), the American Association of Clinical Endocrinologists (AACE), the American Society of Endocrinology (ACE), and the Italian Association of Clinical Endocrinologists (AME) have recognized this method. It is recommended as an important means to evaluate the nature of thyroid nodules. Compared with quasi-static elastic imaging and strain ratio imaging, two-dimensional real-time SWE imaging provides a color-coded map of regional elastic value, quantitatively measures tissue hardness in kPa, and improves the positive predictive value. Papillary thyroid carcinoma mainly comprises diffuse and scattered sandy calcifications and collagen in papillary proliferative thyroid epithelial cells, tissues, stromal tissues, and hardened fibrous matrices. Studies [25, 26] have confirmed that the Young’s modulus varies in different thyroid tissues; the young’s modulus of normal thyroid tissues, cysts, thyroid adenomas, nodular goiters, and thyroid papillary carcinoma increased in turn. This study found that SWE-Max and SWE-ratio were independent risk factors for predicting thyroid cancer, which was consistent with Bardet S et al.’s [27] study. The European Federation of ultrasound (EFSUM) and the World Federation of ultrasound (WFUMB) released clinical application guidelines or an expert consensus of pre- and post-elastic imaging, affirming its value in examining benign and malignant thyroid nodules.
benign and malignant thyroid nodules. These guidelines clearly show that the applications of elastic imaging in evaluating thyroid nodules cannot replace conventional US but can be used as an auxiliary approach. In this study, a nomogram was constructed by combining grayscale US features with real-time SWE imaging to predict the risk of thyroid cancer. After internal verification by bootstrap and self-sampling, the C-index was 0.979 with high accuracy; the combination of the two improves the diagnostic efficiency. Compared to traditional TI-RADS, the model developed in this study can accurately determine the risk value of thyroid nodules rather than the interval range. Compared with the nomogram model constructed using grayscale ultrasound alone by other authors [28], the nomogram model constructed by combining grayscale ultrasound and shear wave elastography in this study showed good discrimination, with an AUC of 0.976 and good calibration.
Limitations
There were some shortcomings in this study. First, this is a single-center study with a small sample size. Thus, we need to expand the sample size to improve the accuracy of the nomogram. Second, US-FNAB may lead to wrong puncture results. Third, the nomogram model passed an internal verification, but it also needs to pass an external verification to clarify the model’s abilities.
Conclusions
In conclusion, the nomogram developed in this study represents a significant step forward in the diagnosis of thyroid cancer. Our novel nomogram integrated grayscale US characteristics and SWE measurements and provided a more accurate and comprehensive risk assessment for thyroid cancer. Compared with the traditional TI-RADS system, our proposed nomogram provides a simpler tool for the risk stratification of thyroid nodules. This innovation has the potential to improve the accuracy of thyroid cancer diagnosis and could ultimately lead to better patient outcomes.
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules:a Review.JAMA2018;319(9):914–24. https://doi.org/10.1001/jama.2018.0898.
Yin J, Wang C, Shao Q, Qu D, Song Z, Shan P, Zhang T, Xu J, Liang Q, Zhang S, Huang J. Relationship between the prevalence of thyroid nodules and metabolic syndrome in the iodine-adequate area of Hangzhou, China: a cross-sectional and Cohort Study. Int J Endocrinol. 2014;2014:675796. https://doi.org/10.1155/2014/675796.
Xu W, Chen Z, Li N, Liu H, Huo L, Huang Y, Jin X, Deng J, Zhu S, Zhang S, Yu Y. Relationship of anthropometric measurements to thyroid nodules in a chinese population. BMJ Open. 2015;5(12):e008452. https://doi.org/10.1136/bmjopen-2015-008452.
Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, Jung HK, Choi JS, Kim BM, Kim EK. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892–9. https://doi.org/10.1148/radiol.11110206.
Koc AM, Adıbelli ZH, Erkul Z, Sahin Y, Dilek I. Comparison of diagnostic accuracy of ACR-TIRADS, american thyroid association (ATA), and EU-TIRADS guidelines in detecting thyroid malignancy. Eur J Radiol. 2020;133:109390. https://doi.org/10.1016/j.ejrad.2020.109390. Epub 2020 Nov 2. PMID: 33181485.
Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M. Le système TIRADS en échographie thyroïdienne [The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound of the thyroid]. J Radiol. 2011 Jul-Aug;92(7–8):701 – 13. French. https://doi.org/10.1016/j.jradio.2011.03.022. Epub 2011 Jul 13. PMID: 21819912.
Rahimi M, Farshchian N, Rezaee E, Shahebrahimi K, Madani H. To differentiate benign from malignant thyroid nodule comparison of sonography with FNAC findings. Pak J Med Sci. 2013;29(1):77–80. https://doi.org/10.12669/pjms.291.2595. PMID: 24353512; PMCID: PMC3809174.
Akhavan A, Jafari SM, Khosravi MH, Khajehpour H, Karimi-Sari H. Reliability of fine-needle aspiration and ultrasound-based characteristics of thyroid nodules for diagnosing malignancy in iranian patients. Diagn Cytopathol. 2016;44(4):269–73. https://doi.org/10.1002/dc.23430. Epub 2016 Jan 18. PMID: 26780293.
Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. J Clin Endocrinol Metab. 2020;105(9):2869–83. https://doi.org/10.1210/clinem/dgaa322. PMID: 32491169; PMCID: PMC7365695.
NAL CLUB. Retrospective evaluation of Ultrasound features of thyroid nodules to assess malignancy risk: a step toward TIRADS. AJR Am J Roentgenol. 2016;207(3):460–9. https://doi.org/10.2214/AJR.15.15121. Epub 2016 Jun 28. PMID: 27352123.
Zhou J, Yin L, Wei X, Zhang S, Song Y, Luo B, Li J, Qian L, Cui L, Chen W, Wen C, Peng Y, Chen Q, Lu M, Chen M, Wu R, Zhou W, Xue E, Li Y, Yang L, Mi C, Zhang R, Wu G, Du G, Huang D, Zhan W. Superficial organ and vascular Ultrasound Group of the Society of Ultrasound in Medicine of the Chinese Medical Association; chinese Artificial Intelligence Alliance for thyroid and breast ultrasound. 2020 chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 2020;70(2):256–79. https://doi.org/10.1007/s12020-020-02441-y. Epub 2020 Aug 21. PMID: 32827126.
Sigrist RMS, Liau J, Kaffas AE, Chammas MC, Willmann JK. Ultrasound Elastography: review of techniques and clinical applications. Theranostics. 2017;7(5):1303–29. https://doi.org/10.7150/thno.18650. PMID: 28435467; PMCID: PMC5399595.
Kim H, Kim JA, Son EJ, Youk JH. Quantitative assessment of shear-wave ultrasound elastography in thyroid nodules: diagnostic performance for predicting malignancy. Eur Radiol. 2013;23(9):2532–7. https://doi.org/10.1007/s00330-013-2847-5. Epub 2013 Apr 19. PMID: 23604801.
Hang J, Li F, Qiao XH, Ye XH, Li A, Du LF. Combination of Maximum Shear Wave elasticity Modulus and TIRADS improves the diagnostic specificity in characterizing thyroid nodules: a retrospective study. Int J Endocrinol 2018 Oct 9;2018:4923050. https://doi.org/10.1155/2018/4923050. PMID: 30402095; PMCID: PMC6198550.
Veyrieres JB, Albarel F, Lombard JV, Berbis J, Sebag F, Oliver C, Petit P. A threshold value in Shear Wave elastography to rule out malignant thyroid nodules: a reality? Eur J Radiol. 2012;81(12):3965–72. https://doi.org/10.1016/j.ejrad.2012.09.002. Epub 2012 Sep 30. PMID: 23031543.
Mao A, An N, Wang J, Wu Y, Wang T, Wang Z, Guan H, Wang J. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma. Endocrine. 2021;73(3):617–24. Epub 2021 Mar 23. PMID: 33755880.
Luongo C, Morra R, Gambale C, Porcelli T, Sessa F, Matano E, Damiano V, Klain M, Schlumberger M, Salvatore D. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy. J Endocrinol Invest. 2021 Feb 12. https://doi.org/10.1007/s40618-021-01508-5. Epub ahead of print. PMID: 33576954.
Xiao J, Xiao Q, Cong W, et al. Discriminating malignancy in thyroid nodules: the Nomogram Versus the Kwak and ACR TI-RADS. Otolaryngol Head Neck Surg. 2020;163(6):1156–65. https://doi.org/10.1177/0194599820939071.
Wang J, Chen L, Nie Y, Wu W, Yao Y. Nomogram for Predicting the overall survival of patients with breast Cancer with pathologic nodal status N3. Clin Breast Cancer. 2020;20(6):e778–85. https://doi.org/10.1016/j.clbc.2020.06.002. Epub 2020 Jun 7. PMID: 32636150.
Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301–12. Epub 2020 Jun 18. PMID: 32558385; PMCID: PMC7365459.
Gittleman H, Sloan AE, Barnholtz-Sloan JS. An independently validated survival nomogram for lower-grade glioma. Neuro Oncol. 2020;22(5):665–74. https://doi.org/10.1093/neuonc/noz191. PMID: 31621885; PMCID: PMC7229246.
Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, Murad MH, Morris JC, Montori VM. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(4):1253–63. https://doi.org/10.1210/jc.2013-2928. Epub 2013 Nov 25. PMID: 24276450; PMCID: PMC3973781.
Golbert L, de Cristo AP, Faccin CS, Farenzena M, Folgierini H, Graudenz MS, Maia AL. Serum TSH levels as a predictor of malignancy in thyroid nodules: a prospective study. PLoS ONE. 2017;12(11):e0188123. https://doi.org/10.1371/journal.pone.0188123. PMID: 29145466; PMCID: PMC5690674.
Khider MO, Ayad C, Suliman AG, Alshoabi SA, Gameraddin M, Elzaki M, Alsharif W, Arafat M, Alali A, Abu Odeh K. Can Thyrotropin, Tri-Iodothyronine, and Thyroxine Hormones be predictors of Cancer in thyroid lesions? Cureus. 2022;14(12):e32422. https://doi.org/10.7759/cureus.32422. PMID: 36644055; PMCID: PMC9832318.
Zhang B, Ma X, Wu N, Liu L, Liu X, Zhang J, Yang J, Niu T. Shear wave elastography for differentiation of benign and malignant thyroid nodules: a meta-analysis. J Ultrasound Med. 2013;32(12):2163–9. https://doi.org/10.7863/ultra.32.12.2163. PMID: 24277899.).
Yoo MH, Kim HJ, Choi IH, Park S, Yun S, Park HK, Byun DW, Suh K. Efficacy of Differential diagnosis of thyroid nodules by Shear Wave Elastography-the stiffness map. J Endocr Soc. 2021;5(11):bvab154. https://doi.org/10.1210/jendso/bvab154. PMID: 34703960; PMCID: PMC8533983.
Bardet S, Ciappuccini R, Pellot-Barakat C, Monpeyssen H, Michels JJ, Tissier F, Blanchard D, Menegaux F, de Raucourt D, Lefort M, Reznik Y, Rouxel A, Heutte N, Brenac F, Leconte A, Buffet C, Clarisse B, Leenhardt L. Shear Wave Elastography in thyroid nodules with indeterminate cytology: results of a prospective bicentric study. Thyroid. 2017;27(11):1441–9. https://doi.org/10.1089/thy.2017.0293. PMID: 28982296.
Guo BL, Ouyang FS, Ouyang LZ, Liu ZW, Lin SJ, Meng W, Huang XY, Chen HX, Yang SM, Hu QG. Development and validation of an ultrasound-based nomogram to improve the diagnostic accuracy for malignant thyroid nodules. Eur Radiol. 2019;29(3):1518–1526. doi: 10.1007/s00330-018-5715-5. Epub 2018 Sep 12. PMID: 30209592.
Funding
No funding.
Author information
Authors and Affiliations
Contributions
The author declares that this work is completed by them and will bear the claims and responsibilities related to this article. Tiantian Ren and Chaoxue Zhang: Study design. Fan Zhang and Jiawei Wu: Data collection. Mingfei Jiang: Analyses, interpretation, and writing of the final manuscript. The authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The retrospective study was carried out in accordance with releveant guidelines and regulations or declaration of Helsinki and was approved by the ethics committee of Maanshan people’s Hospital (2019019). The ethics committee of Maanshan people’s Hospital (2019019) waived the requirement for informed consent due to its retrospective status.
Consent for publication
Not Applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ren, T., Jiang, M., Wu, J. et al. Clinical value of grayscale ultrasound combined with real-time shear wave elastography nomogram in risk prediction of thyroid cancer. BMC Med Imaging 23, 123 (2023). https://doi.org/10.1186/s12880-023-01099-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12880-023-01099-y